# Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/open-label-multicenter-phase-ii-study-of-rc48-adc-a-her2-targeting-antibody-drug/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xinan Sheng,Xieqiao Yan,Lin Wang,Yanxia Shi,Xin Yao,Hong Luo,Benkang Shi,Jiyan Liu,Zhisong He,Guohua Yu,Jianming Ying,Weiqing Han,Chang-Lu Hu,Yun Ling,Zhihong Chi,Chuanliang Cui,Lu Si,Jianmin Fang,Aiping Zhou,Jun Guo |
| Citations | 285 |
| DOI | 10.1158/1078-0432.ccr-20-2488 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/27/1/43/2066899/43.pdf |
| OpenAlex ID | https://openalex.org/W3095210001 |
| PMID | 33109737 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Lin Wang](https://scholariq.org/researchers/lin-wang-3/)
- [Jianming Ying](https://scholariq.org/researchers/jianming-ying/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.